Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

An R2R3 MYB transcription factor determines red petal colour in an Actinidia (kiwifruit) hybrid population.

Fraser LG, Seal AG, Montefiori M, McGhie TK, Tsang GK, Datson PM, Hilario E, Marsh HE, Dunn JK, Hellens RP, Davies KM, McNeilage MA, De Silva HN, Allan AC.

BMC Genomics. 2013 Jan 16;14:28. doi: 10.1186/1471-2164-14-28.

2.

Cost-effectiveness of white blood cell growth factor use among a large nationwide cohort of elderly non-Hodgkin's lymphoma patients treated with chemotherapy.

Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL.

Value Health. 2011 Mar-Apr;14(2):253-62. doi: 10.1016/j.jval.2010.09.010.

3.

Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy.

Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL.

J Am Geriatr Soc. 2010 Oct;58(10):1885-95. doi: 10.1111/j.1532-5415.2010.03081.x. Epub 2010 Sep 14.

PMID:
20840455
4.

Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.

Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL.

Cancer. 2010 Nov 15;116(22):5279-89. doi: 10.1002/cncr.25525.

5.

Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency.

Dimmock DP, Dunn JK, Feigenbaum A, Rupar A, Horvath R, Freisinger P, Mousson de Camaret B, Wong LJ, Scaglia F.

Liver Transpl. 2008 Oct;14(10):1480-5. doi: 10.1002/lt.21556.

6.

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB; ALLHAT Collaborative Research Group.

JAMA. 2005 Apr 6;293(13):1595-608.

PMID:
15811979
7.

A method for estimating duration of illness in Alzheimer's disease.

Doody RS, Dunn JK, Huang E, Azher S, Kataki M.

Dement Geriatr Cogn Disord. 2004;17(1-2):1-4. Epub 2003 Oct 13.

PMID:
14560058
8.

Diagnostic and hematologic features of probable essential thrombocythemia in two dogs.

Dunn JK, Heath MF, Jefferies AR, Blackwood L, McKay JS, Nicholls PK.

Vet Clin Pathol. 1999;28(4):131-138.

PMID:
12075509
9.

Quantitation and prevalence of tympanosclerosis in a pediatric otolaryngology clinic.

Friedman EM, Sprecher RC, Simon S, Dunn JK.

Int J Pediatr Otorhinolaryngol. 2001 Sep 28;60(3):205-11.

PMID:
11551611
10.

Evaluation of a culturally appropriate intervention to increase physical activity.

Poston WS 2nd, Haddock CK, Olvera NE, Suminski RR, Reeves RS, Dunn JK, Hanis CL, Foreyt JP.

Am J Health Behav. 2001 Jul-Aug;25(4):396-406.

PMID:
11488550
11.

Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.

Doody RS, Dunn JK, Clark CM, Farlow M, Foster NL, Liao T, Gonzales N, Lai E, Massman P.

Dement Geriatr Cogn Disord. 2001 Jul-Aug;12(4):295-300.

PMID:
11351141
12.

A method for estimating progression rates in Alzheimer disease.

Doody RS, Massman P, Dunn JK.

Arch Neurol. 2001 Mar;58(3):449-54.

PMID:
11255449
13.

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.

Ballantyne CM, Herd JA, Stein EA, Ferlic LL, Dunn JK, Gotto AM Jr, Marian AJ.

J Am Coll Cardiol. 2000 Nov 1;36(5):1572-8.

14.

Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?

Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L.

J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):668-71.

15.

Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up.

Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH 3rd.

J Am Coll Cardiol. 2000 Sep;36(3):852-5.

16.

Cutaneous T cell lymphoma mimicking cutaneous histiocytosis: differentiation by flow cytometry.

Baines SJ, McCormick D, McInnes E, Dunn JK, Dobson JM, McConnell I.

Vet Rec. 2000 Jul 1;147(1):11-6.

PMID:
10975346
19.

Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.

Sing K, Ballantyne CM, Ferlic L, Brugada R, Cushman I, Dunn JK, Herd JA, Pownall HJ, Gotto AM, Marian AJ.

Atherosclerosis. 1999 Jun;144(2):435-42.

PMID:
10407505
20.

Short-term vitamin E supplementation before marathon running: a placebo-controlled trial.

Buchman AL, Killip D, Ou CN, Rognerud CL, Pownall H, Dennis K, Dunn JK.

Nutrition. 1999 Apr;15(4):278-83.

PMID:
10319359
Items per page

Supplemental Content

Write to the Help Desk